Isordil: Reliable Angina Prevention and Symptom Relief
Isordil
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $1.00 | $60.00 (0%) | 🛒 Add to cart |
| 90 | $0.74 | $90.00 $67.00 (26%) | 🛒 Add to cart |
| 120 | $0.60 | $120.00 $72.00 (40%) | 🛒 Add to cart |
| 180 | $0.50 | $180.00 $90.00 (50%) | 🛒 Add to cart |
| 270 | $0.45 | $270.00 $121.00 (55%) | 🛒 Add to cart |
| 360 | $0.42
Best per pill | $360.00 $151.00 (58%) | 🛒 Add to cart |
| Product dosage: 5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.85 | $51.00 (0%) | 🛒 Add to cart |
| 90 | $0.70 | $76.50 $63.00 (18%) | 🛒 Add to cart |
| 120 | $0.56 | $102.00 $67.00 (34%) | 🛒 Add to cart |
| 180 | $0.42 | $153.00 $75.00 (51%) | 🛒 Add to cart |
| 270 | $0.38 | $229.50 $102.00 (56%) | 🛒 Add to cart |
| 360 | $0.35
Best per pill | $306.00 $126.00 (59%) | 🛒 Add to cart |
Isordil (isosorbide dinitrate) is a potent vasodilator belonging to the organic nitrate class, specifically formulated for the prophylaxis and treatment of angina pectoris. It functions by relaxing vascular smooth muscle, predominantly in the veins, thereby reducing preload and myocardial oxygen demand. This mechanism provides effective and predictable relief from anginal episodes, supporting enhanced physical capacity and quality of life in patients with coronary artery disease. Its well-established pharmacokinetic profile ensures consistent therapeutic performance when administered as directed.
Features
- Active ingredient: Isosorbide dinitrate
- Available formulations: Sublingual tablets, chewable tablets, oral tablets, extended-release capsules
- Rapid onset of action with sublingual administration (2–5 minutes)
- Duration of effect varies by formulation (from 1–2 hours up to 8–12 hours for sustained-release)
- Standard strengths: 5 mg, 10 mg, 20 mg, 30 mg, 40 mg
- Prescription-only medication
Benefits
- Reduces frequency and severity of angina attacks
- Decreases myocardial oxygen demand through venous and arterial dilation
- Increases exercise tolerance in patients with chronic stable angina
- Provides rapid symptomatic relief during acute episodes
- Supports long-term angina management with extended-release formulations
- Contributes to improved quality of life through reliable symptom control
Common use
Isordil is primarily indicated for the prevention and treatment of angina pectoris resulting from coronary artery disease. It is used in both acute settings (sublingual or chewable formulations) for immediate relief of anginal pain and as prophylactic therapy (oral tablets or sustained-release formulations) to prevent anticipated angina episodes, particularly before physical exertion or stressful situations. Some off-label uses include adjunctive therapy in congestive heart failure and esophageal spasm management, though these applications require careful medical supervision.
Dosage and direction
Dosage must be individualized based on patient response, formulation, and clinical context. For sublingual administration: 2.5–10 mg every 2–3 hours as needed for acute angina, placed under the tongue until dissolved. Oral tablets: 5–40 mg taken 2–4 times daily, typically on an empty stomach. Sustained-release capsules: 40 mg once or twice daily, swallowed whole without crushing or chewing. To prevent tolerance development, a nitrate-free interval of 10–14 hours is recommended, typically overnight. Patients should be instructed to sit or lie down when taking initial doses due to potential orthostatic hypotension.
Precautions
Patients should be monitored for signs of hypotension, especially during initial dose titration. Use with caution in patients with hypovolemia, hypotension, or inferior wall myocardial infarction involving right ventricular involvement. Headache is common initially and typically diminishes with continued therapy; analgesics may be used but dose reduction should be considered if headaches persist. Abrupt discontinuation may precipitate rebound angina. Periodic assessment of hemodynamic response and anginal pattern is recommended. Elderly patients may require lower doses due to increased sensitivity.
Contraindications
Isordil is contraindicated in patients with known hypersensitivity to nitrates or any component of the formulation. Absolute contraindications include use with phosphodiesterase-5 inhibitors (sildenafil, tadalafil, vardenafil) due to risk of profound hypotension. Additional contraindications include severe anemia, increased intracranial pressure, and circulatory failure associated with marked hypotension. It should not be used in patients with cardiogenic shock unless adequate filling pressures are maintained.
Possible side effects
The most common adverse effects are headache (which may be severe initially but often diminishes with continued therapy) and hypotension, which may manifest as dizziness, lightheadedness, or syncope. Less frequently reported effects include tachycardia, flushing, nausea, vomiting, and cutaneous vasodilation with flushing. Rare but serious adverse effects include methemoglobinemia (particularly with overdose), paradoxical angina (especially with abrupt withdrawal), and increased intraocular pressure. Most side effects are dose-dependent and often manageable with dose adjustment.
Drug interaction
Concomitant use with phosphodiesterase-5 inhibitors is absolutely contraindicated due to risk of life-threatening hypotension. Additive hypotensive effects may occur with other vasodilators, calcium channel blockers, beta-blockers, antihypertensives, alcohol, and tricyclic antidepressants. Aspirin may increase nitrate serum concentrations. Heparin effectiveness may be reduced. Ergot alkaloids may antagonize the vasodilatory effects. Concurrent use with riociguat should be avoided due to hypotensive potentiation.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next scheduled dose. Do not double the dose to make up for a missed administration. For scheduled prophylactic dosing, maintain the regular dosing schedule. For as-needed sublingual dosing, take when angina symptoms occur according to prescribed parameters. Patients should not alter their dosing regimen without medical consultation.
Overdose
Nitrate overdose manifests primarily as vasodilation leading to severe hypotension, syncope, tachycardia, flushing, headache, dizziness, and methemoglobinemia. Management includes placing patient in Trendelenburg position, administering intravenous fluids, and using alpha-adrenergic agonists if needed. Methylene blue (1–2 mg/kg IV) is indicated for methemoglobinemia exceeding 30%. Hemodialysis is not effective due to extensive tissue distribution. Supportive care with continuous hemodynamic monitoring is essential.
Storage
Store at controlled room temperature (20–25°C or 68–77°F) in original container with lid tightly closed. Protect from light, moisture, and heat. Do not store in bathroom or kitchen where humidity fluctuates. Sublingual tablets must be protected from air exposure to maintain potency. Discard any tablets that do not produce a burning or tingling sensation when placed under the tongue, as this may indicate loss of potency. Keep out of reach of children and pets.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Isordil is a prescription medication that should be used only under the supervision of a qualified healthcare professional. Individual response to therapy may vary. Patients should not initiate, discontinue, or change dosage without medical consultation. Always follow the specific instructions provided by your prescribing physician and refer to the official prescribing information for complete details.
Reviews
Clinical studies demonstrate Isordil’s efficacy in reducing angina frequency by 50-70% in appropriately selected patients. Cardiology guidelines consistently recommend nitrates as first-line therapy for angina prophylaxis. Patients report significant improvement in exercise tolerance and quality of life measures. The sublingual formulation is particularly valued for its rapid onset during acute episodes. Some patients note the development of tolerance with continuous dosing, which is effectively managed through nitrate-free intervals. The safety profile is well-established through decades of clinical use with appropriate monitoring.